{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:18:01Z","timestamp":1778861881937,"version":"3.51.4"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10787-026-02212-7","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T01:48:22Z","timestamp":1775699302000},"page":"2819-2842","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of vitamin D3 supplementation on systemic inflammation and disease-specific markers in patients with autoimmune diseases: a comprehensive meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"34","author":[{"given":"Amirreza","family":"Jabbari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadi","family":"Esmaeili Gouvarchin Ghaleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Alimohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedeh Mahdieh","family":"Khoshnazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Eslami Mahmoudabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiavash","family":"Hushmandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"issue":"2","key":"2212_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s10067-014-2713-0","volume":"34","author":"FE Abourazzak","year":"2015","unstructured":"Abourazzak FE, Talbi S, Aradoini N, Berrada K, Keita S, Hazry T (2015) 25-Hydroxy vitamin D and its relationship with clinical and laboratory parameters in patients with rheumatoid arthritis. Clin Rheumatol 34(2):353\u2013357","journal-title":"Clin Rheumatol"},{"issue":"2","key":"2212_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/ncpendmet0716","volume":"4","author":"JS Adams","year":"2008","unstructured":"Adams JS, Hewison M (2008) Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 4(2):80\u201390","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"1-5","key":"2212_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jsbmb.2004.03.013","volume":"89-90","author":"L Adorini","year":"2004","unstructured":"Adorini L, Penna G, Giarratana N, Roncari A, Amuchastegui S, Daniel KC et al (2004) Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands. J Steroid Biochem Mol Biol 89\u201390(1\u20135):437\u2013441","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2212_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jneuroim.2015.01.005","volume":"280","author":"J \u00c5ivo","year":"2015","unstructured":"\u00c5ivo J, H\u00e4nninen A, Ilonen J, Soilu-H\u00e4nninen M (2015) Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta. J Neuroimmunol 280:12\u201315","journal-title":"J Neuroimmunol"},{"issue":"5","key":"2212_CR5","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/nutrit\/nuad083","volume":"82","author":"H Al-Saoodi","year":"2024","unstructured":"Al-Saoodi H, Kolahdooz F, Andersen JR, Jalili M (2024) Effect of vitamin D on inflammatory and clinical outcomes in patients with rheumatoid arthritis: a systematic review and dose\u2013response meta-analysis of randomized controlled trials. Nutr Rev 82(5):600\u2013611","journal-title":"Nutr Rev"},{"issue":"3","key":"2212_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11154-016-9405-9","volume":"18","author":"B Altieri","year":"2017","unstructured":"Altieri B, Muscogiuri G, Barrea L, Mathieu C, Vallone CV, Mascitelli L et al (2017) Does Vitamin D play a role in autoimmune endocrine disorders? A proof of concept. Rev Endocr Metab Disord 18(3):335\u2013346","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"2212_CR7","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2310\/JIM.0b013e31821b8755","volume":"59","author":"C Aranow","year":"2011","unstructured":"Aranow C (2011) Vitamin D and the immune system. J Investig Med 59(6):881\u2013886","journal-title":"J Investig Med"},{"issue":"6","key":"2212_CR8","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1159\/000439278","volume":"22","author":"F Ashtari","year":"2015","unstructured":"Ashtari F, Toghianifar N, Zarkesh-Esfahani SH, Mansourian M (2015) Short-term effect of high-dose vitamin D on the level of interleukin 10 in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial. NeuroImmunoModulation 22(6):400\u2013404","journal-title":"NeuroImmunoModulation"},{"key":"2212_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103693","volume":"60","author":"E Bahmani","year":"2022","unstructured":"Bahmani E, Hoseini R, Amiri E (2022) Home-based aerobic training and vitamin D improve neurotrophins and inflammatory biomarkers in MS patients. Mult Scler Relat Disord 60:103693","journal-title":"Mult Scler Relat Disord"},{"issue":"9","key":"2212_CR10","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.2337\/dc10-0814","volume":"33","author":"C Bizzarri","year":"2010","unstructured":"Bizzarri C, Pitocco D, Napoli N, Di Stasio E, Maggi D, Manfrini S et al (2010) No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care 33(9):1962\u20131963","journal-title":"Diabetes Care"},{"issue":"9","key":"2212_CR11","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","volume":"167","author":"A Boonstra","year":"2001","unstructured":"Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O\u2019Garra A (2001) 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 167(9):4974\u20134980","journal-title":"J Immunol"},{"issue":"6","key":"2212_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178463","volume":"12","author":"I Buondonno","year":"2017","unstructured":"Buondonno I, Rovera G, Sassi F, Rigoni MM, Lomater C, Parisi S et al (2017) Vitamin D and immunomodulation in early rheumatoid arthritis: a randomized double-blind placebo-controlled study. PLoS ONE 12(6):e0178463","journal-title":"PLoS ONE"},{"issue":"23","key":"2212_CR13","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1212\/WNL.0b013e3181e1cec2","volume":"74","author":"JM Burton","year":"2010","unstructured":"Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, Cheung R et al (2010) A phase I\/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 74(23):1852\u20131859","journal-title":"Neurology"},{"issue":"6","key":"2212_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1212\/WNL.0b013e318259e123","volume":"79","author":"SE Bushnell","year":"2012","unstructured":"Bushnell SE, Zhao Z, Stebbins CC, Cadavid D, Buko AM, Whalley ET et al (2012) Serum IL-17F does not predict poor response to IM IFN\u03b2-1a in relapsing-remitting MS. Neurology 79(6):531\u2013537","journal-title":"Neurology"},{"issue":"3","key":"2212_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1515\/jbcpp-2017-0121","volume":"29","author":"C Cakici","year":"2018","unstructured":"Cakici C, Yigitbasi T, Ayla S, Karimkhani H, Bayramoglu F, Yigit P et al (2018) Dose-dependent effects of vitamin 1, 25 (OH) 2D3 on oxidative stress and apoptosis. J Basic Clin Physiol Pharmacol 29(3):271\u2013279","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"5","key":"2212_CR16","doi-asserted-by":"publisher","first-page":"e597","DOI":"10.1212\/NXI.0000000000000597","volume":"6","author":"W Camu","year":"2019","unstructured":"Camu W, Lehert P, Pierrot-Deseilligny C, Hautecoeur P, Besserve A, Jean Deleglise AS et al (2019) Cholecalciferol in relapsing-remitting MS: a randomized clinical trial (CHOLINE). Neurol Neuroimmunol Neuroinflamm. 6(5):e597","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"issue":"15","key":"2212_CR17","doi-asserted-by":"publisher","first-page":"7861","DOI":"10.1073\/pnas.93.15.7861","volume":"93","author":"MT Cantorna","year":"1996","unstructured":"Cantorna MT, Hayes CE, DeLuca HF (1996) 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A 93(15):7861\u20137864","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2212_CR18","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/oby.2008.657","volume":"17","author":"JF Carroll","year":"2009","unstructured":"Carroll JF, Fulda KG, Chiapa AL, Rodriquez M, Phelps DR, Cardarelli KM et al (2009) Impact of race\/ethnicity on the relationship between visceral fat and inflammatory biomarkers. Obesity (Silver Spring) 17(7):1420\u20131427","journal-title":"Obesity (Silver Spring)"},{"issue":"7","key":"2212_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/1756-185X.12770","volume":"20","author":"S Chandrashekara","year":"2017","unstructured":"Chandrashekara S, Patted A (2017) Role of vitamin D supplementation in improving disease activity in rheumatoid arthritis: an exploratory study. Int J Rheum Dis 20(7):825\u2013831","journal-title":"Int J Rheum Dis"},{"key":"2212_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jaut.2017.07.007","volume":"85","author":"F Colotta","year":"2017","unstructured":"Colotta F, Jansson B, Bonelli F (2017) Modulation of inflammatory and immune responses by Vitamin D. J Autoimmun 85:78\u201397","journal-title":"J Autoimmun"},{"issue":"3","key":"2212_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1568-9972(03)00006-5","volume":"2","author":"GS Cooper","year":"2003","unstructured":"Cooper GS, Stroehla BC (2003) The epidemiology of autoimmune diseases. Autoimmun Rev 2(3):119\u2013125","journal-title":"Autoimmun Rev"},{"issue":"Pt 5","key":"2212_CR22","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/brain\/awp033","volume":"132","author":"J Correale","year":"2009","unstructured":"Correale J, Ysrraelit MC, Gait\u00e1n MI (2009) Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 132(Pt 5):1146\u20131160","journal-title":"Brain"},{"issue":"1-2","key":"2212_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jns.2011.06.027","volume":"311","author":"J Correale","year":"2011","unstructured":"Correale J, Ysrraelit MC, Gait\u00e1n MI (2011) Vitamin D-mediated immune regulation in multiple sclerosis. J Neurol Sci 311(1\u20132):23\u201331","journal-title":"J Neurol Sci"},{"issue":"4","key":"2212_CR24","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/ard.2007.072736","volume":"67","author":"KH Costenbader","year":"2008","unstructured":"Costenbader KH, Feskanich D, Holmes M, Karlson EW, Benito-Garcia E (2008) Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 67(4):530\u2013535","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2212_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1172\/JCI1050","volume":"101","author":"D D\u2019ambrosio","year":"1998","unstructured":"D\u2019ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R et al (1998) Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 101(1):252\u2013262","journal-title":"J Clin Invest"},{"issue":"2","key":"2212_CR26","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1249\/MSS.0b013e3181b117ca","volume":"42","author":"CE Donges","year":"2010","unstructured":"Donges CE, Duffield R, Drinkwater EJ (2010) Effects of resistance or aerobic exercise training on interleukin-6, C-reactive protein, and body composition. Med Sci Sports Exerc 42(2):304\u2013313","journal-title":"Med Sci Sports Exerc"},{"issue":"2","key":"2212_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/exd.12300","volume":"23","author":"G Drozdenko","year":"2014","unstructured":"Drozdenko G, Heine G, Worm M (2014) Oral vitamin D increases the frequencies of CD38+ human B cells and ameliorates IL-17-producing T cells. Exp Dermatol 23(2):107\u2013112","journal-title":"Exp Dermatol"},{"issue":"2","key":"2212_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.5114\/reum\/187391","volume":"62","author":"S Elfituri","year":"2024","unstructured":"Elfituri S (2024) The effects of vitamin D supplementation on disease activity and fatigue in Libyan rheumatoid arthritis patients. Reumatologia 62(2):109\u2013114","journal-title":"Reumatologia"},{"issue":"1-2","key":"2212_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jns.2015.01.030","volume":"350","author":"ZS Farsani","year":"2015","unstructured":"Farsani ZS, Behmanesh M, Sahraian MA (2015) Interleukin-10 but not transforming growth factor-\u03b21 gene expression is up-regulated by vitamin D treatment in multiple sclerosis patients. J Neurol Sci 350(1\u20132):18\u201323","journal-title":"J Neurol Sci"},{"key":"2212_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.clim.2016.02.011","volume":"166-167","author":"L Fawaz","year":"2016","unstructured":"Fawaz L, Mrad MF, Kazan JM, Sayegh S, Akika R, Khoury SJ (2016) Comparative effect of 25(OH)D3 and 1,25(OH)2D3 on Th17 cell differentiation. Clin Immunol 166\u2013167:59\u201371","journal-title":"Clin Immunol"},{"issue":"3","key":"2212_CR31","first-page":"406","volume":"54","author":"F Fiblia","year":"2022","unstructured":"Fiblia F, Rengganis I, Purnamasari D, Widhani A, Karjadi TH, Shatri H et al (2022) Effect of cholecalciferol supplementation on disease activity and quality of life of systemic lupus erythematosus patients: a randomized clinical trial study. Acta Med Indones 54(3):406\u2013413","journal-title":"Acta Med Indones"},{"issue":"9","key":"2212_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222313","volume":"14","author":"SA Fisher","year":"2019","unstructured":"Fisher SA, Rahimzadeh M, Brierley C, Gration B, Doree C, Kimber CE et al (2019) The role of vitamin D in increasing circulating T regulatory cell numbers and modulating T regulatory cell phenotypes in patients with inflammatory disease or in healthy volunteers: a systematic review. PLoS ONE 14(9):e0222313","journal-title":"PLoS ONE"},{"issue":"7","key":"2212_CR33","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1001\/archpediatrics.2012.164","volume":"166","author":"MA Gabbay","year":"2012","unstructured":"Gabbay MA, Sato MN, Finazzo C, Duarte AJ, Dib SA (2012) Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual \u03b2-cell function in new-onset type 1 diabetes mellitus. Arch Pediatr Adolesc Med 166(7):601\u2013607","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2212_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.950465","volume":"14","author":"A Ghaseminejad-Raeini","year":"2023","unstructured":"Ghaseminejad-Raeini A, Ghaderi A, Sharafi A, Nematollahi-Sani B, Moossavi M, Derakhshani A et al (2023) Immunomodulatory actions of vitamin D in various immune-related disorders: a comprehensive review. Front Immunol 14:950465","journal-title":"Front Immunol"},{"key":"2212_CR35","doi-asserted-by":"crossref","unstructured":"Giustina A, Adler RA, Binkley N, Bollerslev J, Bouillon R, Dawson-Hughes B, et al (2020) Consensus statement from 2(nd) International Conference on Controversies in Vitamin D. Rev Endocr Metab Disord. 21(1):89\u2013116","DOI":"10.1007\/s11154-019-09532-w"},{"key":"2212_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1471-2377-13-60","volume":"13","author":"D Golan","year":"2013","unstructured":"Golan D, Halhal B, Glass-Marmor L, Staun-Ram E, Rozenberg O, Lavi I et al (2013) Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties. BMC Neurol 13:60","journal-title":"BMC Neurol"},{"issue":"9","key":"2212_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1772","volume":"10","author":"K H\u00e4nninen","year":"2020","unstructured":"H\u00e4nninen K, J\u00e4\u00e4skel\u00e4inen O, Herukka SK, Soilu-H\u00e4nninen M (2020) Vitamin D supplementation and serum neurofilament light chain in interferon-beta-1b-treated MS patients. Brain Behav 10(9):e01772","journal-title":"Brain Behav"},{"issue":"10","key":"2212_CR38","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.autrev.2012.02.001","volume":"11","author":"SM Hayter","year":"2012","unstructured":"Hayter SM, Cook MC (2012) Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev 11(10):754\u2013765","journal-title":"Autoimmun Rev"},{"issue":"8","key":"2212_CR39","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1002\/eji.200838216","volume":"38","author":"G Heine","year":"2008","unstructured":"Heine G, Niesner U, Chang HD, Steinmeyer A, Z\u00fcgel U, Zuberbier T et al (2008) 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur J Immunol 38(8):2210\u20132218","journal-title":"Eur J Immunol"},{"issue":"5","key":"2212_CR40","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jocn.2012.10.005","volume":"20","author":"S Hewer","year":"2013","unstructured":"Hewer S, Lucas R, van der Mei I, Taylor BV (2013) Vitamin D and multiple sclerosis. J Clin Neurosci 20(5):634\u2013641","journal-title":"J Clin Neurosci"},{"key":"2212_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-3-030-46227-7_2","volume":"1268","author":"MF Holick","year":"2020","unstructured":"Holick MF (2020) Sunlight, UV radiation, vitamin D, and skin cancer: How much sunlight do we need? Adv Exp Med Biol 1268:19\u201336","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"2212_CR42","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/ane.13037","volume":"139","author":"T Holm\u00f8y","year":"2019","unstructured":"Holm\u00f8y T, R\u00f8sj\u00f8 E, Zetterberg H, Blennow K, Lindstr\u00f8m JC, Steffensen LH et al (2019) Vitamin D supplementation and neurofilament light chain in multiple sclerosis. Acta Neurol Scand 139(2):172\u2013176","journal-title":"Acta Neurol Scand"},{"issue":"1-2","key":"2212_CR43","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jneuroim.2004.08.014","volume":"158","author":"YM Huang","year":"2005","unstructured":"Huang YM, Adikari S, B\u00e5ve U, Sanna A, Alm G (2005) Multiple sclerosis: interferon-beta induces CD123(+)BDCA2- dendritic cells that produce IL-6 and IL-10 and have no enhanced type I interferon production. J Neuroimmunol 158(1\u20132):204\u2013212","journal-title":"J Neuroimmunol"},{"issue":"8","key":"2212_CR44","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.2337\/db10-1661","volume":"60","author":"A Hughson","year":"2011","unstructured":"Hughson A, Bromberg I, Johnson B, Quataert S, Jospe N, Fowell DJ (2011) Uncoupling of proliferation and cytokines from suppression within the CD4+CD25+Foxp3+ T-cell compartment in the 1st year of human type 1 diabetes. Diabetes 60(8):2125\u20132133","journal-title":"Diabetes"},{"issue":"17","key":"2212_CR45","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1128\/MCB.05020-11","volume":"31","author":"S Joshi","year":"2011","unstructured":"Joshi S, Pantalena LC, Liu XK, Gaffen SL, Liu H, Rohowsky-Kochan C et al (2011) 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol 31(17):3653\u20133669","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2212_CR46","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1023\/A:1010062929140","volume":"2","author":"PW Jurutka","year":"2001","unstructured":"Jurutka PW, Whitfield GK, Hsieh JC, Thompson PD, Haussler CA, Haussler MR (2001) Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev Endocr Metab Disord 2(2):203\u2013216","journal-title":"Rev Endocr Metab Disord"},{"key":"2212_CR47","doi-asserted-by":"publisher","first-page":"552","DOI":"10.22159\/ajpcr.2018.v11i10.28936","volume":"11","author":"K Kadhim","year":"2018","unstructured":"Kadhim K, Nafea L, Gasim G, Fawzi H, Hameed E (2018) Assessment of vitamin D therapy effect on inflammatory markers in pediatric patients with type I diabetic. Asian J Pharm Clin Res 11:552\u2013554","journal-title":"Asian J Pharm Clin Res"},{"issue":"3","key":"2212_CR48","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3892\/mmr.2013.1256","volume":"7","author":"AP Kallaur","year":"2013","unstructured":"Kallaur AP, Oliveira SR, Colado Sim\u00e3o AN, Delicato de Almeida ER, Kaminami Morimoto H, Lopes J et al (2013) Cytokine profile in relapsing-remitting multiple sclerosis patients and the association between progression and activity of the disease. Mol Med Rep 7(3):1010\u20131020","journal-title":"Mol Med Rep"},{"issue":"8","key":"2212_CR49","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1177\/1352458511434607","volume":"18","author":"MT Kampman","year":"2012","unstructured":"Kampman MT, Steffensen LH, Mellgren SI, J\u00f8rgensen L (2012) Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial. Mult Scler 18(8):1144\u20131151","journal-title":"Mult Scler"},{"key":"2212_CR50","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/1735-1995.199089","volume":"22","author":"H Karimzadeh","year":"2017","unstructured":"Karimzadeh H, Shirzadi M, Karimifar M (2017) The effect of vitamin D supplementation in disease activity of systemic lupus erythematosus patients with vitamin D deficiency: a randomized clinical trial. J Res Med Sci 22:4","journal-title":"J Res Med Sci"},{"issue":"3","key":"2212_CR51","doi-asserted-by":"publisher","first-page":"428","DOI":"10.31138\/mjr.090725.lar","volume":"36","author":"Z Khatirnamani","year":"2025","unstructured":"Khatirnamani Z, Hajian-Tilaki K, Heidari B, Sohrabi A (2025) The effect of vitamin D supplementation on clinical and laboratory biomarkers in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomised controlled trials. Mediterr J Rheumatol 36(3):428\u2013439","journal-title":"Mediterr J Rheumatol"},{"issue":"1\u20132","key":"2212_CR52","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jns.2014.10.003","volume":"347","author":"S Kimball","year":"2014","unstructured":"Kimball S, Hanwell HE, Burton JM, Heaney RP, Holick MF, Hollis B et al (2014) Vitamin D supplementation in multiple sclerosis: making a case for clarity. J Neurol Sci 347(1\u20132):391\u2013392","journal-title":"J Neurol Sci"},{"issue":"5","key":"2212_CR53","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1177\/1352458507087136","volume":"14","author":"M Krakauer","year":"2008","unstructured":"Krakauer M, Sorensen P, Khademi M, Olsson T, Sellebjerg F (2008) Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression. Mult Scler 14(5):622\u2013630","journal-title":"Mult Scler"},{"issue":"6","key":"2212_CR54","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.semarthrit.2010.07.009","volume":"40","author":"MA Kriegel","year":"2011","unstructured":"Kriegel MA, Manson JE, Costenbader KH (2011) Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Semin Arthritis Rheum 40(6):512\u201331.e8","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"2212_CR55","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3109\/03009749309099266","volume":"22","author":"H Kr\u00f6ger","year":"1993","unstructured":"Kr\u00f6ger H, Penttil\u00e4 IM, Alhava EM (1993) Low serum vitamin D metabolites in women with rheumatoid arthritis. Scand J Rheumatol 22(4):172\u2013177","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"2212_CR56","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1172\/JCI115072","volume":"87","author":"JM Lemire","year":"1991","unstructured":"Lemire JM, Archer DC (1991) 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 87(3):1103\u20131107","journal-title":"J Clin Invest"},{"issue":"6 Suppl","key":"2212_CR57","doi-asserted-by":"publisher","first-page":"1704s","DOI":"10.1093\/jn\/125.suppl_6.1704S","volume":"125","author":"JM Lemire","year":"1995","unstructured":"Lemire JM, Archer DC, Beck L, Spiegelberg HL (1995) Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 125(6 Suppl):1704s-s1708","journal-title":"J Nutr"},{"key":"2212_CR58","doi-asserted-by":"publisher","first-page":"9127","DOI":"10.12659\/MSM.911628","volume":"24","author":"C Li","year":"2018","unstructured":"Li C, Yin S, Yin H, Cao L, Zhang T, Wang Y (2018) Efficacy and safety of 22-Oxa-Calcitriol in patients with rheumatoid arthritis: a Phase II trial. Med Sci Monit 24:9127\u20139135","journal-title":"Med Sci Monit"},{"issue":"1","key":"2212_CR59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/acr.22621","volume":"68","author":"GL Lima","year":"2016","unstructured":"Lima GL, Paupitz J, Aikawa NE, Takayama L, Bonfa E, Pereira RM (2016) Vitamin D supplementation in adolescents and young adults with Juvenile Systemic Lupus Erythematosus for improvement in disease activity and fatigue scores: a randomized, double-blind, placebo-controlled trial. Arthritis Care Res (Hoboken) 68(1):91\u201398","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"2212_CR60","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.4049\/jimmunol.174.4.2061","volume":"174","author":"LA Lyakh","year":"2005","unstructured":"Lyakh LA, Sanford M, Chekol S, Young HA, Roberts AB (2005) TGF-beta and vitamin D3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells. J Immunol 174(4):2061\u20132070","journal-title":"J Immunol"},{"issue":"1-2","key":"2212_CR61","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jneuroim.2010.11.008","volume":"233","author":"AP Lysandropoulos","year":"2011","unstructured":"Lysandropoulos AP, Jaqui\u00e9ry E, Jilek S, Pantaleo G, Schluep M, Du Pasquier RA (2011) Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects. J Neuroimmunol 233(1\u20132):240\u2013244","journal-title":"J Neuroimmunol"},{"issue":"5","key":"2212_CR62","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/jcb.10580","volume":"89","author":"BD Mahon","year":"2003","unstructured":"Mahon BD, Wittke A, Weaver V, Cantorna MT (2003a) The targets of Vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89(5):922\u2013932","journal-title":"J Cell Biochem"},{"issue":"1-2","key":"2212_CR63","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0165-5728(02)00396-X","volume":"134","author":"BD Mahon","year":"2003","unstructured":"Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT (2003b) Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 134(1\u20132):128\u2013132","journal-title":"J Neuroimmunol"},{"key":"2212_CR64","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3389\/fendo.2018.00550","volume":"9","author":"E Marcinowska-Suchowierska","year":"2018","unstructured":"Marcinowska-Suchowierska E, Kupisz-Urba\u0144ska M, \u0141ukaszkiewicz J, P\u0142udowski P, Jones G (2018) Vitamin D toxicity\u2013a clinical perspective. Front Endocrinol 9:550","journal-title":"Front Endocrinol"},{"issue":"1-5","key":"2212_CR65","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jsbmb.2004.03.014","volume":"89-90","author":"C Mathieu","year":"2004","unstructured":"Mathieu C, van Etten E, Decallonne B, Guilietti A, Gysemans C, Bouillon R et al (2004) Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system. J Steroid Biochem Mol Biol 89\u201390(1\u20135):449\u2013452","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"11","key":"2212_CR66","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.bbamcr.2010.07.009","volume":"1803","author":"JM Matilainen","year":"2010","unstructured":"Matilainen JM, Husso T, Toropainen S, Seuter S, Turunen MP, Gynther P et al (2010) Primary effect of 1\u03b1,25(OH)2D3 on IL-10 expression in monocytes is short-term down-regulation. Biochim Biophys Acta 1803(11):1276\u20131286","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2212_CR67","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/art.11434","volume":"50","author":"LA Merlino","year":"2004","unstructured":"Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG (2004) Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women\u2019s Health Study. Arthritis Rheum 50(1):72\u201377","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2212_CR68","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s00296-020-04607-3","volume":"40","author":"M Miler","year":"2020","unstructured":"Miler M, Nikolac Gabaj N, Grazio S, Vahtari\u0107 A, Vrtari\u0107 A, Grubi\u0161i\u0107 F et al (2020) Lower concentration of vitamin D is associated with lower DAS28 and VAS-pain scores in patients with inflammatory rheumatic diseases treated with infliximab: a pilot study. Rheumatol Int 40(9):1455\u20131461","journal-title":"Rheumatol Int"},{"issue":"6","key":"2212_CR69","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3109\/08820139.2011.573041","volume":"40","author":"G Mosayebi","year":"2011","unstructured":"Mosayebi G, Ghazavi A, Ghasami K, Jand Y, Kokhaei P (2011) Therapeutic effect of vitamin D3 in multiple sclerosis patients. Immunol Invest 40(6):627\u2013639","journal-title":"Immunol Invest"},{"issue":"5","key":"2212_CR70","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/ana.21972","volume":"67","author":"EM Mowry","year":"2010","unstructured":"Mowry EM, Krupp LB, Milazzo M, Chabas D, Strober JB, Belman AL et al (2010) Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol 67(5):618\u2013624","journal-title":"Ann Neurol"},{"issue":"2","key":"2212_CR71","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/ana.23591","volume":"72","author":"EM Mowry","year":"2012","unstructured":"Mowry EM, Waubant E, McCulloch CE, Okuda DT, Evangelista AA, Lincoln RR et al (2012) Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann Neurol 72(2):234\u2013240","journal-title":"Ann Neurol"},{"issue":"9","key":"2212_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102350","volume":"18","author":"G Murdaca","year":"2019","unstructured":"Murdaca G, Tonacci A, Negrini S, Greco M, Borro M, Puppo F et al (2019) Emerging role of vitamin D in autoimmune diseases: An update on evidence and therapeutic implications. Autoimmun Rev 18(9):102350","journal-title":"Autoimmun Rev"},{"key":"2212_CR73","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jneuroim.2016.09.018","volume":"300","author":"AH Muris","year":"2016","unstructured":"Muris AH, Smolders J, Rolf L, Thewissen M, Hupperts R, Damoiseaux J (2016) Immune regulatory effects of high dose vitamin D(3) supplementation in a randomized controlled trial in relapsing remitting multiple sclerosis patients receiving IFN\u03b2; the SOLARIUM study. J Neuroimmunol 300:47\u201356","journal-title":"J Neuroimmunol"},{"issue":"7","key":"2212_CR74","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/jnr.20826","volume":"83","author":"G Muthian","year":"2006","unstructured":"Muthian G, Raikwar HP, Rajasingh J, Bright JJ (2006) 1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12\/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis. J Neurosci Res 83(7):1299\u20131309","journal-title":"J Neurosci Res"},{"key":"2212_CR75","first-page":"134","volume":"42","author":"L Nafea","year":"2017","unstructured":"Nafea L, Kadhim K, Al-Dubuni A, Sadik H (2017) Evaluation the effect of vitamin D3 on Glycemic indices on Iraqi children with type 1 DM. Int J Pharmaceut Sci Rev Res 42:134\u2013143","journal-title":"Int J Pharmaceut Sci Rev Res"},{"key":"2212_CR76","unstructured":"Nafei LT, Kadhim KA, Said AM, Ghani SH (eds.) Evaluation the effect of vitamin D 3 on glycemic indices on iraqi children with type 1 DM2017"},{"issue":"1-2","key":"2212_CR77","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jneuroim.2014.03.011","volume":"270","author":"M Niino","year":"2014","unstructured":"Niino M, Fukazawa T, Miyazaki Y, Takahashi E, Minami N, Amino I et al (2014) Suppression of IL-10 production by calcitriol in patients with multiple sclerosis. J Neuroimmunol 270(1\u20132):86\u201394","journal-title":"J Neuroimmunol"},{"issue":"2","key":"2212_CR78","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1074\/jbc.M110.163790","volume":"286","author":"MT Palmer","year":"2011","unstructured":"Palmer MT, Lee YK, Maynard CL, Oliver JR, Bikle DD, Jetten AM et al (2011) Lineage-specific effects of 1,25-dihydroxyvitamin D(3) on the development of effector CD4 T cells. J Biol Chem 286(2):997\u20131004","journal-title":"J Biol Chem"},{"key":"2212_CR79","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.934475","volume":"27","author":"DV Parums","year":"2021","unstructured":"Parums DV (2021) Review articles, systematic reviews, meta-analysis, and the updated preferred reporting items for systematic reviews and meta-analyses (PRISMA) 2020 guidelines. Med Sci Monit 27:e934475-1","journal-title":"Med Sci Monit"},{"issue":"8","key":"2212_CR80","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/j.1464-5491.2006.01921.x","volume":"23","author":"D Pitocco","year":"2006","unstructured":"Pitocco D, Crin\u00f2 A, Di Stasio E, Manfrini S, Guglielmi C, Spera S et al (2006) The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Diabet Med 23(8):920\u2013923","journal-title":"Diabet Med"},{"issue":"7","key":"2212_CR81","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3390\/nu14071483","volume":"14","author":"P Pludowski","year":"2022","unstructured":"Pludowski P, Takacs I, Boyanov M, Belaya Z, Diaconu CC, Mokhort T et al (2022) Clinical practice in the prevention, diagnosis and treatment of vitamin D deficiency: a central and eastern European expert consensus statement. Nutrients 14(7):1483","journal-title":"Nutrients"},{"issue":"1","key":"2212_CR82","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s41927-025-00543-6","volume":"9","author":"M Rexhepi","year":"2025","unstructured":"Rexhepi M, Krasniqi B, Hoti K, Daci A, Rexhepi-Kelmendi B, Krasniqi S (2025) Impact of vitamin D supplementation on disease activity and pain management in rheumatoid arthritis: a randomized double-blinded controlled study. BMC Rheumatol 9(1):87","journal-title":"BMC Rheumatol"},{"key":"2212_CR83","doi-asserted-by":"publisher","first-page":"231053","DOI":"10.37275\/ijr.v8i2.59","volume":"8","author":"A Rifa\u2019i","year":"2018","unstructured":"Rifa\u2019i A, Kalim H, Kusworini K, Wahono C (2018) Effect of vitamin D supplementation on disease activity (SLEDAI) and fatigue in systemic lupus erythematosus patients with hipovitamin D: an open clinical trial. Indones. J Rheumatol 8:231053","journal-title":"Indones. J Rheumatol"},{"key":"2212_CR84","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jns.2017.04.017","volume":"378","author":"L Rolf","year":"2017","unstructured":"Rolf L, Muris AH, Bol Y, Damoiseaux J, Smolders J, Hupperts R (2017) Vitamin D(3) supplementation in multiple sclerosis: symptoms and biomarkers of depression. J Neurol Sci 378:30\u201335","journal-title":"J Neurol Sci"},{"key":"2212_CR85","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.molimm.2018.12.001","volume":"105","author":"L Rolf","year":"2019","unstructured":"Rolf L, Smolders J, van den Ouweland J, Hupperts R, Damoiseaux J (2019) Correlation of different cellular assays to analyze T cell-related cytokine profiles in vitamin D(3)-supplemented patients with Multiple Sclerosis. Mol Immunol 105:198\u2013204","journal-title":"Mol Immunol"},{"issue":"12","key":"2212_CR86","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1007\/s00415-015-7902-5","volume":"262","author":"E R\u00f8sj\u00f8","year":"2015","unstructured":"R\u00f8sj\u00f8 E, Steffensen LH, J\u00f8rgensen L, Lindstr\u00f8m JC, \u0160altyt\u0117 Benth J, Michelsen AE et al (2015) Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis. J Neurol 262(12):2713\u20132721","journal-title":"J Neurol"},{"issue":"7","key":"2212_CR87","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s00296-011-1944-5","volume":"32","author":"M Salesi","year":"2012","unstructured":"Salesi M, Farajzadegan Z (2012) Efficacy of vitamin D in patients with active rheumatoid arthritis receiving methotrexate therapy. Rheumatol Int 32(7):2129\u20132133","journal-title":"Rheumatol Int"},{"issue":"8","key":"2212_CR88","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/1352458515606986","volume":"22","author":"L Sandberg","year":"2016","unstructured":"Sandberg L, Bistr\u00f6m M, Salzer J, V\u00e5gberg M, Svenningsson A, Sundstr\u00f6m P (2016) Vitamin D and axonal injury in multiple sclerosis. Mult Scler 22(8):1027\u20131031","journal-title":"Mult Scler"},{"issue":"4","key":"2212_CR89","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/ajcn\/83.4.754","volume":"83","author":"SS Schleithoff","year":"2006","unstructured":"Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R (2006) Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 83(4):754\u2013759","journal-title":"Am J Clin Nutr"},{"key":"2212_CR90","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jsbmb.2017.06.006","volume":"177","author":"R Scragg","year":"2018","unstructured":"Scragg R (2018) Limitations of vitamin D supplementation trials: why observational studies will continue to help determine the role of vitamin D in health. J Steroid Biochem Mol Biol 177:6\u20139","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"9","key":"2212_CR91","first-page":"SC15","volume":"11","author":"S Sharma","year":"2017","unstructured":"Sharma S, Biswal N, Bethou A, Rajappa M, Kumar S, Vinayagam V (2017) Does vitamin D supplementation improve glycaemic control in children with type 1 diabetes mellitus?\u2014A randomized controlled trial. J Clin Diagn Res 11(9):SC15\u2013SC17","journal-title":"J Clin Diagn Res"},{"issue":"2","key":"2212_CR92","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ana.22043","volume":"68","author":"S Simpson Jr","year":"2010","unstructured":"Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H et al (2010) Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 68(2):193\u2013203","journal-title":"Ann Neurol"},{"issue":"1","key":"2212_CR93","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12020-015-0547-4","volume":"50","author":"T Skaaby","year":"2015","unstructured":"Skaaby T, Husemoen LL, Thuesen BH, Linneberg A (2015) Prospective population-based study of the association between Vitamin D status and incidence of autoimmune disease. Endocrine 50(1):231\u2013238","journal-title":"Endocrine"},{"key":"2212_CR94","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/B978-0-12-386960-9.00018-6","volume":"86","author":"J Smolders","year":"2011","unstructured":"Smolders J, Damoiseaux J (2011) Vitamin D as a T-cell modulator in multiple sclerosis. Vitam Horm 86:401\u2013428","journal-title":"Vitam Horm"},{"issue":"8","key":"2212_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006635","volume":"4","author":"J Smolders","year":"2009","unstructured":"Smolders J, Thewissen M, Peelen E, Menheere P, Tervaert JW, Damoiseaux J et al (2009) Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS ONE 4(8):e6635","journal-title":"PLoS ONE"},{"issue":"12","key":"2212_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015235","volume":"5","author":"J Smolders","year":"2010","unstructured":"Smolders J, Peelen E, Thewissen M, Cohen Tervaert JW, Menheere P, Hupperts R et al (2010a) Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis. PLoS ONE 5(12):e15235","journal-title":"PLoS ONE"},{"issue":"1-2","key":"2212_CR97","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jsbmb.2010.03.001","volume":"121","author":"J Smolders","year":"2010","unstructured":"Smolders J, Menheere P, Thewissen M, Peelen E, Tervaert JW, Hupperts R et al (2010b) Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis. J Steroid Biochem Mol Biol 121(1\u20132):243\u2013246","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"2212_CR98","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/ane.13185","volume":"141","author":"J Smolders","year":"2020","unstructured":"Smolders J, Mimpen M, Oechtering J, Damoiseaux J, van den Ouweland J, Hupperts R et al (2020) Vitamin D(3) supplementation and neurofilament light chain in multiple sclerosis. Acta Neurol Scand 141(1):77\u201380","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"2212_CR99","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/jnnp-2011-301876","volume":"83","author":"M Soilu-H\u00e4nninen","year":"2012","unstructured":"Soilu-H\u00e4nninen M, Aivo J, Lindstr\u00f6m BM, Elovaara I, Sumelahti ML, F\u00e4rkkil\u00e4 M et al (2012) A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon \u03b2-1b in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 83(5):565\u2013571","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"2212_CR100","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1212\/WNL.0000000000002316","volume":"86","author":"ES Sotirchos","year":"2016","unstructured":"Sotirchos ES, Bhargava P, Eckstein C, Van Haren K, Baynes M, Ntranos A et al (2016) Safety and immunologic effects of high- vs. low-dose cholecalciferol in multiple sclerosis. Neurology 86(4):382\u2013390","journal-title":"Neurology"},{"key":"2212_CR101","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1749-6632.2011.06351.x","volume":"1247","author":"M Stassen","year":"2012","unstructured":"Stassen M, Schmitt E, Bopp T (2012) From interleukin-9 to T helper 9 cells. Ann N Y Acad Sci 1247:56\u201368","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"2212_CR102","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1212\/WNL.0b013e31825fded9","volume":"79","author":"N Stewart","year":"2012","unstructured":"Stewart N, Simpson S Jr., van der Mei I, Ponsonby AL, Blizzard L, Dwyer T et al (2012) Interferon-\u03b2 and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS. Neurology 79(3):254\u2013260","journal-title":"Neurology"},{"issue":"2","key":"2212_CR103","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/sji.12403","volume":"83","author":"I Szymczak","year":"2016","unstructured":"Szymczak I, Pawliczak R (2016) The active metabolite of vitamin D3 as a potential immunomodulator. Scand J Immunol 83(2):83\u201391","journal-title":"Scand J Immunol"},{"key":"2212_CR104","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jneuroim.2015.05.022","volume":"285","author":"N Toghianifar","year":"2015","unstructured":"Toghianifar N, Ashtari F, Zarkesh-Esfahani SH, Mansourian M (2015) Effect of high dose vitamin D intake on Interleukin-17 levels in Multiple Sclerosis: a randomized, double-blind, placebo-controlled clinical trial. J Neuroimmunol 285:125\u2013128","journal-title":"J Neuroimmunol"},{"issue":"2","key":"2212_CR105","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.clim.2015.08.002","volume":"161","author":"G Treiber","year":"2015","unstructured":"Treiber G, Prietl B, Fr\u00f6hlich-Reiterer E, Lechner E, Ribitsch A, Fritsch M et al (2015a) Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset Type 1 Diabetes Mellitus - a randomized clinical trial. Clin Immunol 161(2):217\u2013224","journal-title":"Clin Immunol"},{"issue":"2","key":"2212_CR106","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.clim.2015.08.002","volume":"161","author":"G Treiber","year":"2015","unstructured":"Treiber G, Prietl B, Fr\u00f6hlich-Reiterer E, Lechner E, Ribitsch A, Fritsch M et al (2015b) Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus\u2014a randomized clinical trial. Clin Immunol 161(2):217\u2013224","journal-title":"Clin Immunol"},{"issue":"11","key":"2212_CR108","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/s41430-020-0697-1","volume":"74","author":"R Vieth","year":"2020","unstructured":"Vieth R (2020) Vitamin D supplementation: cholecalciferol, calcifediol, and calcitriol. Eur J Clin Nutr 74(11):1493\u20131497","journal-title":"Eur J Clin Nutr"},{"issue":"12","key":"2212_CR109","doi-asserted-by":"publisher","first-page":"9821","DOI":"10.1007\/s11033-020-05780-1","volume":"47","author":"IA Voutsadakis","year":"2020","unstructured":"Voutsadakis IA (2020) Vitamin D receptor (VDR) and metabolizing enzymes CYP27B1 and CYP24A1 in breast cancer. Mol Biol Rep 47(12):9821\u20139830","journal-title":"Mol Biol Rep"},{"issue":"1","key":"2212_CR110","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12937-024-00990-w","volume":"23","author":"C-H Wang","year":"2024","unstructured":"Wang C-H, Porta L, Yang T-K, Wang Y-H, Wu T-H, Qian F et al (2024) Optimal methods of vitamin D supplementation to prevent acute respiratory infections: a systematic review, dose\u2013response and pairwise meta-analysis of randomized controlled trials. Nutr J 23(1):92","journal-title":"Nutr J"},{"issue":"1-2","key":"2212_CR111","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.mce.2011.08.016","volume":"347","author":"H Wolden-Kirk","year":"2011","unstructured":"Wolden-Kirk H, Overbergh L, Christesen HT, Brusgaard K, Mathieu C (2011) Vitamin D and diabetes: its importance for beta cell and immune function. Mol Cell Endocrinol 347(1\u20132):106\u2013120","journal-title":"Mol Cell Endocrinol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02212-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02212-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02212-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:03:01Z","timestamp":1778860981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02212-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":110,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2212"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02212-7","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study protocol was reviewed and approved by the Nephrology and Urology Research Center, Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, the Islamic Republic of Iran, approval number [\n                      IR.BMSU.BAQ.REC.1404.003\n                      ].","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}